Proprietary interest in the tested product

Under 21 CFR 54, sponsors must certify or disclose such interests held by clinical investigators in covered studies that support marketing applications. FDA uses the information to judge whether the data could be biased.

Proprietary interest in the tested product means property or other financial interest in the product including, but not limited to, a patent, trademark, copyright or licensing agreement.

21 CFR, 54.2